ORMDL3 restrains type-I interferon signaling and anti-tumor immunity by promoting RIG-I degradation
Qi Zeng, Yao Chen, Shimeng Zhang, Yizhi Mao, Jing Wang, Ziyang Wang, Chunjie Sheng, Shuai Chen
This study identifies ORMDL3 as a negative regulator of type-I interferon signaling by promoting RIG-I degradation, which impacts anti-tumor immunity.
eLife · Mar 24, 2025Peer-reviewedMolecular Biology